Symbols

LCI(Delisted)

Lannett·NYSE

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About LCI

Lannett Company, Inc.

A company that offers generic pharmaceutical products for a wide range of medical indications

Industry

Established Date

Listing Date

12/13/2013

Exchange

New York Stock Exchange

Full-time Employees

560

Fiscal Year Ends

06-30

Website

www.lannett.com

Security Type

Common stock

Office address

1150 Northbrook Drive, Suite 155, Trevose, Pennsylvania 19053

Business

Introduction

Lannett Company, Inc., and its subsidiaries were incorporated under the laws of the Commonwealth of Pennsylvania in 1942 and re-registered as a Delaware corporation in 1991. The company mainly develops, manufactures, sells and distributes generic drugs of branded drugs.

Company Financials

EPS

LCI has released its 2023 Q2 earnings. EPS was reported at -1.36, versus the expected -1.64, beating expectations. The chart below visualizes how LCI has performed over recent quarters, highlighting trends in earnings surprises.